Emodepside is an innovative anthelmintic medication belonging to the cyclooctadepsipeptide drug class, available for cats under the brand name Profender when combined with praziquantel. This topical deworming solution represents a significant advancement in feline parasite control by offering comprehensive intestinal worm treatment through simple skin application rather than oral administration. Profender has gained widespread acceptance in veterinary medicine as a first-line treatment for mixed intestinal worm infections, providing cat owners with a stress-free alternative to traditional oral dewormers that many cats resist. The combination formulation addresses the most common intestinal parasites affecting cats in a single, convenient application.
Emodepside works through a unique mechanism of action that distinguishes it from older anthelmintic drug classes. The medication stimulates presynaptic receptors in parasitic worms, specifically targeting latrophilin-like receptors that regulate neurotransmitter release. This stimulation causes sustained paralysis of the worms' pharyngeal and body wall muscles, preventing feeding and movement. The paralyzed worms are then expelled from the intestinal tract through normal digestive processes. This novel mechanism makes emodepside effective against parasites that may have developed resistance to traditional dewormers, providing an important tool for managing challenging infections.
Profender topical solution is formulated specifically for transdermal absorption in cats, available in pre-measured applicator tubes designed for different weight ranges. The medication is applied to the skin at the base of the skull, where it absorbs through the epidermis and enters systemic circulation to reach intestinal parasites. This topical administration route eliminates the struggles often associated with pilling cats or administering liquid medications orally. A single application treats existing worm infections, with the medication providing rapid clearance of susceptible parasites typically within one to two days of treatment.
The safety profile of emodepside in combination with praziquantel has been well-established through extensive clinical trials and post-market surveillance since the product's introduction. Profender is approved for use in cats and kittens eight weeks of age and older weighing at least 2.2 pounds, making it suitable for the majority of feline patients requiring deworming. As with all antiparasitic medications, proper veterinary diagnosis before treatment ensures appropriate product selection and identifies any individual patient factors that might affect treatment safety or efficacy. Following veterinary guidance on application technique and retreatment intervals optimizes outcomes while minimizing any potential for adverse effects.
